![Study Results & Research Projects Study Results & Research Projects](https://webarchive.library.unt.edu/eot2008/20090131021151im_/http://ntp-server.niehs.nih.gov/images/template/subMastHead_studyResults.gif)
Summaries & Associations of Study Results
Summaries & Associations of Study Results
Home » Study Results & Research Projects » Summaries & Associations of Study Results » Levels from TR-521 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
---|---|---|---|---|
TEF EVALUATION (TCDD) 1746-01-6 |
02/17/04 | ONE OF 5 DIOXIN-LIKE COMPOUNDS PLUS 2 MIXTURES BEING TESTED TO DETERMINE IF THE TOXIC EQUIVALENCY FACTORS (TEFS) FOR THESE CHEMICALS WOULD BE PREDICTIVE OF RODENT CARCINOGENICITY. | Gavage FEMALE RATS ONLY: TCDD -- 0, 3, 10, 22, 46, OR 100 NG/KG; 100/DOSE | Battelle Columbus Laboratory |
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
FR: CLEAR EVIDENCE | LIVER: ADENOMA 0/53 0/54 0/53 0/53 1/53 13/53 2/50 OR CHOLANGIOCARCINOMA 0/53 0/54 0/53 1/53 4/53 25/53 2/50 | |||
LUNG: CYSTIC KERATINIZING EPITHELIOMA 0/53 0/54 0/53 0/52 0/53 9/52 0/50 | ||||
ORAL MUCOSA: GINGIVAL SQAMOUS CELL CARCINOMA 1/53 2/54 1/53 0/53 4/53 10/53 5/50 | ||||
UTERUS: SQUAMOUS CELL CARCINOMA 0/53 0/54 0/53 0/53 5/53 0/53 2/50 | ||||
MAY HAVE BEEN RELATED: | PANCREAS ACINAR CELL: ADENOMA OR CARCINOMA 0/51 0/54 0/52 0/53 0/52 3/51 1/49 | |||
LIVER: HEPATOCHOLANGIOMA 0/53 0/54 0/53 0/53 0/53 2/53 0/50 OR CHOLANGIOMA 0/53 0/54 0/53 0/53 0/53 0/53 1/50 | ||||
NON-NEOPLASTIC LESIONS: | LIVER: HEPATOCYTE HYPERTROPHY; MULTINUCLEATED HEPATOCYTE; EOSINOPHILIC FOCUS; INFLAMMATION; PIGMENTATION; DIFFUSE FATTY CHANGE; NECROSIS; OVAL CELL HYPERPLASIA; BILE DUCT HYPERPLASIA; BILE DUCT CYST; NODULAR HYPERPLASIA; PORTAL FIBROSIS; TOXIC HEPATOPATHY; CHOLANGIOFIBROSIS | |||
LUNG: ALVEOLAR EPITHELIUM, METAPLASIA, BRONCHIOLAR | ||||
ORAL MUCOSA: GINGIVAL SQUAMOUS HYPERPLASIA | ||||
PANCREAS: ACINAR CYTOPLASMIC VACUOLIZATION; CHRONIC ACTIVE INFLAMMATION; ACINAR ATROPHY; ARTERIAL CHRONIC ACTIVE INFLAMMATION | ||||
THYMUS: ATROPHY; SEVERITY OF ATROPHY | ||||
ADRENAL CORTEX: ATROPHY; HYPERPLASIA | ||||
HEART: CARDIOMYOPATHY | ||||
CLITORAL GLAND: CYSTIC DUCT | ||||
KIDNEY: NEPHROPATHY; SEVERITY OF NEPHROPATHY | ||||
FORESTOMACH: SQUAMOUS HYPERPLASIA | ||||
THYROID GLAND: FOLLICULAR CELL HYPERTROPHY |
Web page last updated on February 10, 2006
The National Institute of Environmental Health Sciences is one of the National Institutes of Health within the U.S. Department of Health and Human Services. The National Toxicology Program is headquartered on the NIEHS campus in Research Triangle Park, NC.